VCP
IMMU

Verus Capital Partners’s Immunomedics Inc IMMU Stock Holding History

Verus Capital Partners’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$54K Buy
+3,992
New +$67.2K 0.02% 473

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Verus Capital Partners's IMMU Position: Q1 2020 in Review

Verus Capital Partners opened a new position in Immunomedics Inc (IMMU) in Q1 2020: 3,992 shares worth $54K. The stake represents 0.02% of the portfolio and ranks #473 among its holdings.

220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Verus Capital Partners held 3,992 shares of Immunomedics Inc worth $54K as of Q1 2020.
  • Immunomedics Inc was a new Verus Capital Partners position in Q1 2020.
  • Immunomedics Inc made up 0.02% of Verus Capital Partners's portfolio in Q1 2020, its #473 holding.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.